Gradientech presents QuickMIC® at FEMS 2023
Gradientech will display its ultra-rapid and precise diagnostic system QuickMIC® at the FEMS Congress of European Microbiologists in Hamburg, Germany 9-13 July 2023.
FEMS 2023 is the biggest event in Europe dedicated to showcasing the latest development of microbiology and connect to microbiologist from all over the world. Established in 1974, FEMS is a diverse federation of 55 European learned societies that includes around 30,000 professionals who are committed to advancing microbiology for the benefit of society.
“We are excited to participate and showcase our innovative QuickMIC system for leading experts in the field. QuickMIC is the fastest phenotypic antibiotic susceptibility testing (AST) system for sepsis samples on the market today with results available within 2-4 hours from positive blood culture and fills a significant need in the microbiology laboratory. In combination with its precise, linear MIC results, we believe we are taking AST to a whole new level of clinical utility", says Sara Thorslund, CEO of Gradientech.
Gradientech is proud to be a sponsor of the FEMS 2023 event and is looking forward to connecting with significant contacts within this important field. Welcome by our booth B38 to talk to the team and get a demo of the QuickMIC system.
For further information, please contact:
Sara Thorslund, PhD, CEO Gradientech
Tel: +46 736 29 35 80
sara.thorslund@gradientech.se
About Gradientech
Gradientech is leading the field of ultra-rapid antibiotic susceptibility testing. We develop next-generation diagnostics in infectious disease medicine. Our product QuickMIC® allows patients with sepsis to quickly receive specific guidance on the right antibiotic in the right dose. It saves lives, reduces healthcare costs and limits the spread of antibiotic resistance – one of the greatest global health threats of our time. Gradientech is headquartered in Uppsala, Sweden. Visit www.gradientech.se for more information.
